Signals
Novartis India Ltd
NSE :NOVARTIND BSE :500672 Sector : PharmaceuticalsBuy, Sell or Hold NOVARTIND? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
| 25 Oct 672.25 (-2.48%) | 23 Oct 689.35 (-1.87%) | 20 Oct 702.50 (-1.41%) | 19 Oct 712.55 (-0.61%) | 18 Oct 716.95 (0.31%) | 17 Oct 714.75 (0.37%) | 16 Oct 712.10 (-0.93%) | 13 Oct 718.75 (0.86%) | 12 Oct 712.65 (-0.52%) | 11 Oct 716.35 (0.05%) | 10 Oct 716.00 (1.24%) | 09 Oct 707.20 (-1.89%) | 06 Oct 720.85 (-0.11%) | 05 Oct 721.65 (-0.41%) | 04 Oct 724.65 (-0.38%) | 03 Oct 727.40 (0.98%) | 29 Sep 720.35 (0.99%) | 28 Sep 713.30 (0.11%) | 27 Sep 712.50 (-0.79%) | 26 Sep 718.20 (-0.48%) | 25 Sep 721.70 (-0.69%) |
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Neutral
Long Term Investors
Bearish
Moving Averages
5 DMA
Bullish
823.39
10 DMA
Bullish
806.36
20 DMA
Bullish
809.68
50 DMA
Bullish
810.66
100 DMA
Bearish
878.09
200 DMA
Bearish
989.01
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Oct 25, 2023 04:00 PM For Next Trading Session
| Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
|---|---|---|---|---|---|
| R3 | 720.7 | 709.45 | 680.46 | - | - |
| R2 | 709.45 | 698.05 | 677.72 | 707.61 | - |
| R1 | 690.85 | 691 | 674.99 | 687.17 | 700.15 |
| P | 679.6 | 679.6 | 679.6 | 677.76 | 684.25 |
| S1 | 661 | 668.2 | 669.51 | 657.32 | 670.3 |
| S2 | 649.75 | 661.15 | 666.78 | 647.91 | - |
| S3 | 631.15 | 649.75 | 664.04 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Novartis India Ltd Quaterly Results
| INCOME | |
| PROFIT | |
| EPS |
Novartis India Ltd Quaterly Results
| INCOME | 106.5 | 91.59 | 102.7 | 97.43 | 103.6 | |
| PROFIT | 26.57 | 14.68 | 25.74 | 20.41 | 25.45 | |
| EPS | 10.76 | 5.95 | 10.42 | 8.27 | 10.31 |
Profit & Loss (Figures in Rs. Crores)
Novartis India Ltd Profit & Loss
| INCOME | |
| PROFIT | |
| EPS |
Novartis India Ltd Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
| INCOME | 977.97 | 902.97 | 742.43 | 704.76 | 572.89 | 472.56 | 403.7 | 442.18 | 434.5 | 386.89 | |
| PROFIT | 74.96 | 198.29 | 57.22 | 66.11 | 51.76 | 10.09 | 20.87 | 40.96 | 103.19 | 83.2 | |
| EPS | 22.72 | 62.04 | 20.33 | 31.75 | 20.98 | 4.08 | 8.47 | -1.51 | 41.88 | 34.52 |
Balance Sheet (Figures in Rs. Crores)
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
| SOURCES OF FUNDS : | ||||||||||
| Share Capital | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 14.07 | 15.98 | 15.98 |
| Reserves Total | 732.48 | 763.32 | 679.36 | 698.85 | 708.39 | 746.85 | 721.3 | 905.57 | 1,177.6 | 986.01 |
| Total Shareholders Funds | 744.82 | 775.66 | 691.7 | 711.19 | 720.73 | 759.19 | 733.64 | 919.64 | 1,193.58 | 1,001.99 |
| Unsecured Loans | 6.97 | 21.51 | 24.01 | 62.48 | 68.29 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 6.97 | 21.51 | 24.01 | 62.48 | 68.29 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 17.84 | 30.4 | 31.18 | 82.37 | 67.66 | 38.24 | 47.28 | 47.26 | 34.49 | 33.44 |
| Total Liabilities | 769.63 | 827.57 | 746.89 | 856.04 | 856.68 | 797.43 | 780.92 | 966.9 | 1,228.07 | 1,035.43 |
| APPLICATION OF FUNDS : | ||||||||||
| Gross Block | 16.29 | 31.15 | 32.94 | 74.81 | 85.08 | 23.93 | 12.09 | 10.82 | 9.87 | 26.08 |
| Less : Accumulated Depreciation | 9.35 | 11.9 | 9.29 | 10.9 | 8.8 | 8.95 | 7.49 | 5.11 | 3.39 | 17.58 |
| Net Block | 6.94 | 19.25 | 23.65 | 63.91 | 76.28 | 14.98 | 4.6 | 5.71 | 6.48 | 8.5 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.45 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Inventories | 44.86 | 54.72 | 57.07 | 47.95 | 58.68 | 60.51 | 56.56 | 87.52 | 72.4 | 99.94 |
| Sundry Debtors | 41.47 | 36.16 | 44.56 | 38.73 | 37.6 | 45.59 | 43.91 | 40.83 | 50.17 | 82.9 |
| Cash and Bank Balance | 596.08 | 555.94 | 517.63 | 498.88 | 581.91 | 612.02 | 775.08 | 815.72 | 1,125.55 | 838.55 |
| Loans and Advances | 16.85 | 30.51 | 89.47 | 137.57 | 134.94 | 88.35 | 76.6 | 29.07 | 15.57 | 41.99 |
| Total Current Assets | 699.26 | 677.33 | 708.73 | 723.13 | 813.13 | 806.47 | 952.15 | 973.14 | 1,263.69 | 1,063.38 |
| Current Liabilities | 93.25 | 93.58 | 111.8 | 112.14 | 193.76 | 159.02 | 289.58 | 133.6 | 158.6 | 146.76 |
| Provisions | 62.05 | 61.79 | 98.88 | 34.11 | 27.2 | 25.99 | 40.02 | 49.44 | 45.89 | 63.94 |
| Total Current Liabilities & Provisions | 155.3 | 155.37 | 210.68 | 146.25 | 220.96 | 185.01 | 329.6 | 183.04 | 204.49 | 210.7 |
| Net Current Assets | 543.96 | 521.96 | 498.05 | 576.88 | 592.17 | 621.46 | 622.55 | 790.1 | 1,059.2 | 852.68 |
| Deferred Tax Assets | 23.24 | 22.42 | 27.18 | 30.27 | 24.74 | 21.44 | 23.05 | 23.22 | 21.58 | 21.9 |
| Deferred Tax Liability | 7.87 | 6.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Deferred Tax | 15.37 | 15.8 | 27.18 | 30.27 | 24.74 | 21.44 | 23.05 | 23.22 | 21.58 | 21.9 |
| Other Assets | 203.36 | 270.56 | 198.01 | 184.98 | 163.49 | 139.55 | 130.72 | 147.86 | 140.36 | 152.34 |
| Total Assets | 769.63 | 827.57 | 746.89 | 856.04 | 856.68 | 797.43 | 780.92 | 966.9 | 1,228.07 | 1,035.43 |
| Contingent Liabilities | 398.38 | 419.25 | 422.34 | 419.18 | 380.38 | 217.4 | 155.02 | 121.5 | 101.07 | 109.82 |
Cash Flow (Figures in Rs. Crores)
| Net Profit before Tax and Extr... | 122.84 |
| Depreciation | 2.61 |
| Interest (Net) | -53.7 |
| P/L on Sales of Assets | -3.21 |
| Prov. and W/O (Net) | 0.03 |
| P/L in Forex | 0.1 |
| Fin. Lease and Rental Charges | -2.68 |
| Total Adjustments (PBT and Ext... | -56.75 |
| Operating Profit before Workin... | 66.09 |
| Trade and 0ther Receivables | -5.34 |
| Inventories | 9.86 |
| Trade Payables | 2.12 |
| Total Adjustments (OP before W... | 9.04 |
| Cash Generated from/(used in) ... | 75.13 |
| Direct Taxes Paid | 38.27 |
| Total Adjustments(Cash Generat... | 38.27 |
| Cash Flow before Extraordinary... | 113.4 |
| Net Cash from Operating Activi... | 113.4 |
| Interest Received | 34.69 |
| Net Cash used in Investing Act... | 33.13 |
| Of Financial Liabilities | -3.7 |
| Dividend Paid | -117.28 |
| Interest Paid | -0.01 |
| Net Cash used in Financing Act... | -120.99 |
Company Details
Registered Office |
|
| Address | The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E) |
| City | Mumbai |
| State | Maharashtra |
| Pin Code | 400051 |
| Tel. No. | 91-022-50243000 |
| Fax. No. | 91-022-50243010 |
| india.investors@novartis.com | |
| Internet | http://www.novartis.in |
Registrars |
|
| Address | The Inspire BKC Part 601 & 701 |
| City | Mumbai |
| State | Maharashtra |
| Pin Code | 400051 |
| Tel. No. | 91-022-50243000 |
| Fax. No. | 91-022-50243010 |
| india.investors@novartis.com | |
| Internet | http://www.novartis.in |
Management |
|
| Name | Designation |
| C Snook | Chairman (Non-Executive) |
| Sandra Martryes | Independent Director |
| SANKER PARAMESWARAN | Independent Director |
| Shilpa Joshi | Whole Time Director & CFO |
| Chandni Maru | Company Sec. & Compli. Officer |
| Gira Sardesai | Independent Director |
| Falin Majmudar | Whole Time Director |
